NewsBenzingaGoldman Sachs maintient son conseil d'achat sur Marathon Petroleum et augmente son objectif de cours à 472 dollars. Goldman Sachs maintient son conseil d'achat sur Marathon Petroleum et augmente son objectif de cours à 472 dollars. Benzinga 2026.09.21 11:03 (GMT+0) Open on Benzinga Other news Reported Friday, MannKind’s Under-10-Second Furoscix ReadyFlow Autoinjector Shows Urine Output Comparable To IV Furosemide In New HFSA 2026 Analyses, Supporting Outpatient Edema Management In Heart Failure And CKD Robert Reich Slams Republicans Over ‘Trickle-Down’ Economics, Calls Theory a ‘Hoax’ That Enriched America’s Richest 1% Top Analyst Calls Elon Musk’s Next Starship Flight SpaceX’s ‘Biggest Test’ Yet — One Launch Could Replace a Month of Falcon 9 Missions Reported Saturday, Merck’s Remigromig Delivers Mean BCVA Gains Of 9.1 Letters At 0.5 Mg And 8.7 Letters At 0.8 Mg Versus 11.8 For Ranibizumab, Meeting Non-Inferiority, With No Secondary Endpoint Showing Superiority Bybit Supports Stocks Trading, Giving Eligible Global Users Access to 1,000+ U.S. Stocks and ETFs UK Bitcoin treasury company The Smarter Web Company raises $13.25 million through preferred share issuance
Reported Friday, MannKind’s Under-10-Second Furoscix ReadyFlow Autoinjector Shows Urine Output Comparable To IV Furosemide In New HFSA 2026 Analyses, Supporting Outpatient Edema Management In Heart Failure And CKD
Robert Reich Slams Republicans Over ‘Trickle-Down’ Economics, Calls Theory a ‘Hoax’ That Enriched America’s Richest 1%
Top Analyst Calls Elon Musk’s Next Starship Flight SpaceX’s ‘Biggest Test’ Yet — One Launch Could Replace a Month of Falcon 9 Missions
Reported Saturday, Merck’s Remigromig Delivers Mean BCVA Gains Of 9.1 Letters At 0.5 Mg And 8.7 Letters At 0.8 Mg Versus 11.8 For Ranibizumab, Meeting Non-Inferiority, With No Secondary Endpoint Showing Superiority
UK Bitcoin treasury company The Smarter Web Company raises $13.25 million through preferred share issuance
